Annual EPS
-$5.00
-$3.08-160.42%
September 30, 2024
Summary
- As of February 7, 2025, ARWR annual earnings per share is -$5.00, with the most recent change of -$3.08 (-160.42%) on September 30, 2024.
- During the last 3 years, ARWR annual EPS has fallen by -$3.64 (-267.65%).
- ARWR annual EPS is now -105.13% below its all-time high of $97.40, reached on September 30, 1999.
Performance
ARWR EPS Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EPS
-$1.37
+$0.01+0.72%
September 30, 2024
Summary
- As of February 7, 2025, ARWR quarterly earnings per share is -$1.37, with the most recent change of +$0.01 (+0.72%) on September 30, 2024.
- Over the past year, ARWR quarterly EPS has dropped by -$0.35 (-34.31%).
- ARWR quarterly EPS is now -110.29% below its all-time high of $13.31, reached on September 30, 2003.
Performance
ARWR Quarterly EPS Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EPS
-$5.01
-$0.35-7.51%
September 30, 2024
Summary
- As of February 7, 2025, ARWR TTM earnings per share is -$5.01, with the most recent change of -$0.35 (-7.51%) on September 30, 2024.
- Over the past year, ARWR TTM EPS has dropped by -$0.77 (-18.16%).
- ARWR TTM EPS is now -141.38% below its all-time high of $12.11, reached on June 30, 2004.
Performance
ARWR TTM EPS Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EPS Formula
EPS = Net Income - Preferred Dividends
Shares Outstanding
Net Income - Preferred Dividends
Shares Outstanding
Shares Outstanding
ARWR EPS Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -160.4% | -34.3% | -18.2% |
| 3 y3 years | -267.6% | -124.6% | -268.4% |
| 5 y5 years | -824.6% | -124.6% | -268.4% |
ARWR EPS Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -267.6% | at low | -404.4% | +0.7% | -359.6% | at low |
| 5 y | 5-year | -824.6% | at low | -404.4% | +0.7% | -1045.3% | at low |
| alltime | all time | -105.1% | +97.2% | -110.3% | +89.5% | -141.4% | +89.0% |
Arrowhead Pharmaceuticals EPS History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | -$5.00(+160.4%) | -$1.37(-0.7%) | -$5.01(+7.5%) |
| Jun 2024 | - | -$1.38(+35.3%) | -$4.66(+9.9%) |
| Mar 2024 | - | -$1.02(-17.7%) | -$4.24(+53.1%) |
| Dec 2023 | - | -$1.24(+21.6%) | -$2.77(+44.3%) |
| Sep 2023 | -$1.92(+15.0%) | -$1.02(+6.3%) | -$1.92(+12.3%) |
| Jun 2023 | - | -$0.96(-313.3%) | -$1.71(+19.6%) |
| Mar 2023 | - | $0.45(-215.4%) | -$1.43(-2.7%) |
| Dec 2022 | - | -$0.39(-51.9%) | -$1.47(-12.5%) |
| Sep 2022 | -$1.67(+22.8%) | -$0.81(+19.1%) | -$1.68(+13.5%) |
| Jun 2022 | - | -$0.68(-265.9%) | -$1.48(+35.8%) |
| Mar 2022 | - | $0.41(-168.3%) | -$1.09(-38.1%) |
| Dec 2021 | - | -$0.60(-1.6%) | -$1.76(+29.4%) |
| Sep 2021 | -$1.36(+61.9%) | -$0.61(+110.3%) | -$1.36(+10.6%) |
| Jun 2021 | - | -$0.29(+11.5%) | -$1.23(+15.0%) |
| Mar 2021 | - | -$0.26(+30.0%) | -$1.07(+5.9%) |
| Dec 2020 | - | -$0.20(-58.3%) | -$1.01(+20.2%) |
| Sep 2020 | -$0.84(-221.7%) | -$0.48(+269.2%) | -$0.84(+236.0%) |
| Jun 2020 | - | -$0.13(-35.0%) | -$0.25(-377.8%) |
| Mar 2020 | - | -$0.20(+566.7%) | $0.09(-83.0%) |
| Dec 2019 | - | -$0.03(-127.3%) | $0.53(-23.2%) |
| Sep 2019 | $0.69(-206.2%) | $0.11(-47.6%) | $0.69(+50.0%) |
| Jun 2019 | - | $0.21(-12.5%) | $0.46(+557.1%) |
| Mar 2019 | - | $0.24(+84.6%) | $0.07(-120.0%) |
| Dec 2018 | - | $0.13(-208.3%) | -$0.35(-47.0%) |
| Sep 2018 | -$0.65(+38.3%) | -$0.12(-33.3%) | -$0.66(-4.3%) |
| Jun 2018 | - | -$0.18(0.0%) | -$0.69(+19.0%) |
| Mar 2018 | - | -$0.18(0.0%) | -$0.58(+20.8%) |
| Dec 2017 | - | -$0.18(+20.0%) | -$0.48(+2.1%) |
| Sep 2017 | -$0.47(-64.9%) | -$0.15(+114.3%) | -$0.47(-28.8%) |
| Jun 2017 | - | -$0.07(-12.5%) | -$0.66(-27.5%) |
| Mar 2017 | - | -$0.08(-52.9%) | -$0.91(-22.9%) |
| Dec 2016 | - | -$0.17(-50.0%) | -$1.18(-11.3%) |
| Sep 2016 | -$1.34(-16.3%) | -$0.34(+6.3%) | -$1.33(-5.0%) |
| Jun 2016 | - | -$0.32(-8.6%) | -$1.40(+3.7%) |
| Mar 2016 | - | -$0.35(+9.4%) | -$1.35(-10.6%) |
| Dec 2015 | - | -$0.32(-22.0%) | -$1.51(-5.6%) |
| Sep 2015 | -$1.60(+28.0%) | -$0.41(+51.9%) | -$1.60(-1.8%) |
| Jun 2015 | - | -$0.27(-47.1%) | -$1.63(+3.2%) |
| Mar 2015 | - | -$0.51(+24.4%) | -$1.58(+14.5%) |
| Dec 2014 | - | -$0.41(-6.8%) | -$1.38(+10.4%) |
| Sep 2014 | -$1.25(-3.8%) | -$0.44(+100.0%) | -$1.25(+1.5%) |
| Jun 2014 | - | -$0.22(-29.0%) | -$1.23(-0.8%) |
| Mar 2014 | - | -$0.31(+10.7%) | -$1.24(-7.5%) |
| Dec 2013 | - | -$0.28(-33.6%) | -$1.34(-3.6%) |
| Sep 2013 | -$1.30(-31.6%) | -$0.42(+83.2%) | -$1.39(+0.1%) |
| Jun 2013 | - | -$0.23(-43.9%) | -$1.39(-25.7%) |
| Mar 2013 | - | -$0.41(+24.2%) | -$1.87(-4.6%) |
| Dec 2012 | - | -$0.33(-21.4%) | -$1.96(+4.3%) |
| Sep 2012 | -$1.90 | -$0.42(-40.8%) | -$1.88(+1.6%) |
| Jun 2012 | - | -$0.71(+42.0%) | -$1.85(+33.1%) |
| Mar 2012 | - | -$0.50(+100.0%) | -$1.39(+167.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2011 | - | -$0.25(-35.9%) | -$0.52(+10.6%) |
| Sep 2011 | -$0.44(-51.1%) | -$0.39(+56.0%) | -$0.47(+23.7%) |
| Jun 2011 | - | -$0.25(-167.6%) | -$0.38(+65.1%) |
| Mar 2011 | - | $0.37(-284.7%) | -$0.23(-74.4%) |
| Dec 2010 | - | -$0.20(-33.2%) | -$0.90(-10.0%) |
| Sep 2010 | -$0.90(-79.1%) | -$0.30(+200.0%) | -$1.00(-23.1%) |
| Jun 2010 | - | -$0.10(-66.7%) | -$1.30(-27.8%) |
| Mar 2010 | - | -$0.30(0.0%) | -$1.80(-33.3%) |
| Dec 2009 | - | -$0.30(-50.0%) | -$2.70(-37.2%) |
| Sep 2009 | -$4.30(-37.7%) | -$0.60(0.0%) | -$4.30(-25.9%) |
| Jun 2009 | - | -$0.60(-50.0%) | -$5.80(-18.3%) |
| Mar 2009 | - | -$1.20(-36.8%) | -$7.10(-4.1%) |
| Dec 2008 | - | -$1.90(-9.5%) | -$7.40(+7.2%) |
| Sep 2008 | -$6.90(-16.9%) | -$2.10(+10.5%) | -$6.90(+3.0%) |
| Jun 2008 | - | -$1.90(+26.7%) | -$6.70(-18.3%) |
| Mar 2008 | - | -$1.50(+7.1%) | -$8.20(-3.5%) |
| Dec 2007 | - | -$1.40(-26.3%) | -$8.50(+3.7%) |
| Sep 2007 | -$8.30(+38.3%) | -$1.90(-44.1%) | -$8.20(-1.2%) |
| Jun 2007 | - | -$3.40(+88.9%) | -$8.30(+36.1%) |
| Mar 2007 | - | -$1.80(+63.6%) | -$6.10(+3.4%) |
| Dec 2006 | - | -$1.10(-45.0%) | -$5.90(0.0%) |
| Sep 2006 | -$6.00(+122.2%) | -$2.00(+66.7%) | -$5.90(+19.8%) |
| Jun 2006 | - | -$1.20(-25.0%) | -$4.93(-7.5%) |
| Mar 2006 | - | -$1.60(+45.5%) | -$5.33(+55.4%) |
| Dec 2005 | - | -$1.10(+7.1%) | -$3.43(0.0%) |
| Sep 2005 | -$2.70(+42.1%) | -$1.03(-35.8%) | -$3.43(-2.3%) |
| Jun 2005 | - | -$1.60(-633.3%) | -$3.51(+45.7%) |
| Mar 2005 | - | $0.30(-127.3%) | -$2.41(-20.0%) |
| Dec 2004 | - | -$1.10(-0.6%) | -$3.01(+30.4%) |
| Sep 2004 | -$1.90(+533.3%) | -$1.11(+121.3%) | -$2.31(-119.0%) |
| Jun 2004 | - | -$0.50(+66.7%) | $12.11(+98.0%) |
| Mar 2004 | - | -$0.30(-25.0%) | $6.12(-193.1%) |
| Dec 2003 | - | -$0.40(-103.0%) | -$6.57(-48.1%) |
| Sep 2003 | -$0.30(-99.1%) | $13.31(-305.0%) | -$12.67(-67.5%) |
| Jun 2003 | - | -$6.49(-50.0%) | -$38.96(-14.3%) |
| Mar 2003 | - | -$12.99(+100.0%) | -$45.45(+34.8%) |
| Dec 2002 | - | -$6.49(-50.0%) | -$33.72(0.0%) |
| Sep 2002 | -$32.47(+25.0%) | -$12.99(0.0%) | -$33.72(+0.0%) |
| Jun 2002 | - | -$12.99(+939.1%) | -$33.70(+23.8%) |
| Mar 2002 | - | -$1.25(-80.8%) | -$27.22(-16.2%) |
| Dec 2001 | - | -$6.49(-49.9%) | -$32.46(0.0%) |
| Sep 2001 | -$25.97(+33.3%) | -$12.97(+99.6%) | -$32.46(+116.1%) |
| Jun 2001 | - | -$6.50(+0.1%) | -$15.02(+0.0%) |
| Mar 2001 | - | -$6.49(0.0%) | -$15.02(0.0%) |
| Dec 2000 | - | -$6.49(-245.5%) | -$15.02(0.0%) |
| Sep 2000 | -$19.48(-120.0%) | $4.46(-168.7%) | -$15.02(-22.9%) |
| Jun 2000 | - | -$6.49(0.0%) | -$19.48(+50.0%) |
| Mar 2000 | - | -$6.49(0.0%) | -$12.99(+100.0%) |
| Dec 1999 | - | -$6.49 | -$6.49 |
| Sep 1999 | $97.40(-400.0%) | - | - |
| Sep 1998 | -$32.47(-81.5%) | - | - |
| Sep 1997 | -$175.32 | - | - |
FAQ
- What is Arrowhead Pharmaceuticals annual earnings per share?
- What is the all time high annual EPS for Arrowhead Pharmaceuticals?
- What is Arrowhead Pharmaceuticals annual EPS year-on-year change?
- What is Arrowhead Pharmaceuticals quarterly earnings per share?
- What is the all time high quarterly EPS for Arrowhead Pharmaceuticals?
- What is Arrowhead Pharmaceuticals quarterly EPS year-on-year change?
- What is Arrowhead Pharmaceuticals TTM earnings per share?
- What is the all time high TTM EPS for Arrowhead Pharmaceuticals?
- What is Arrowhead Pharmaceuticals TTM EPS year-on-year change?
What is Arrowhead Pharmaceuticals annual earnings per share?
The current annual EPS of ARWR is -$5.00
What is the all time high annual EPS for Arrowhead Pharmaceuticals?
Arrowhead Pharmaceuticals all-time high annual earnings per share is $97.40
What is Arrowhead Pharmaceuticals annual EPS year-on-year change?
Over the past year, ARWR annual earnings per share has changed by -$3.08 (-160.42%)
What is Arrowhead Pharmaceuticals quarterly earnings per share?
The current quarterly EPS of ARWR is -$1.37
What is the all time high quarterly EPS for Arrowhead Pharmaceuticals?
Arrowhead Pharmaceuticals all-time high quarterly earnings per share is $13.31
What is Arrowhead Pharmaceuticals quarterly EPS year-on-year change?
Over the past year, ARWR quarterly earnings per share has changed by -$0.35 (-34.31%)
What is Arrowhead Pharmaceuticals TTM earnings per share?
The current TTM EPS of ARWR is -$5.01
What is the all time high TTM EPS for Arrowhead Pharmaceuticals?
Arrowhead Pharmaceuticals all-time high TTM earnings per share is $12.11
What is Arrowhead Pharmaceuticals TTM EPS year-on-year change?
Over the past year, ARWR TTM earnings per share has changed by -$0.77 (-18.16%)